Share:
Peer-Reviewed Publication
Ann Behav Med2025;59(1)January 4, 2025Editorial

Glass "half full" on obesity and anti-obesity medication health communication.

Robert Hsu1, Anne-Kathrin Eiselt1, Tejaswi Kompala1,2
1Clinical Strategy, Teladoc Health, Purchase, NY 10577, United States.
2Division of Endocrinology, University of Utah Health, Salt Lake City, UT 84108, United States.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.